Research Paper Volume 15, Issue 9 pp 3598—3620
Comprehensive analyses reveal the prognosis and biological function roles of chromatin regulators in lung adenocarcinoma
Figure 8. Chemotherapy sensitivity and immunotherapy response assessment. (A–I) IC50 of nine kinds of chemotherapy drug between high- and low-risk groups. (J–M) Immunotherapy response prediction based on Tumor Immune Dysfunction and Exclude module.